AMENDMENT NO. 3 TO Securities Purchase AgreementSecurities Purchase Agreement • April 4th, 2016 • Cipher Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 4th, 2016 Company Industry JurisdictionThis Amendment No. 3 to Securities Purchase AGREEMENT is entered into as of March 31, 2016 (this “Amendment”), among Cipher Pharmaceuticals INC., an Ontario corporation (the “Issuer”), the Guarantors party hereto, Athyrium Opportunities II Acquisition LP, as a Purchaser, the other Purchasers party hereto (collectively, the “Purchasers”) and Athyrium Opportunities II Acquisition LP, as Collateral Agent.